167 related articles for article (PubMed ID: 29140555)
1. WITHDRAWN: Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder A; Flapan AD; Cordina J
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002903. PubMed ID: 29140555
[TBL] [Abstract][Full Text] [Related]
2. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Elder AT; Flapan AD; Kelman A
Cochrane Database Syst Rev; 2005 Jul; (3):CD002903. PubMed ID: 16034878
[TBL] [Abstract][Full Text] [Related]
3. Electrical cardioversion for atrial fibrillation and flutter.
Mead GE; Flapan AD; Elder AT
Cochrane Database Syst Rev; 2002; (1):CD002903. PubMed ID: 11869642
[TBL] [Abstract][Full Text] [Related]
4. External electrical and pharmacological cardioversion for atrial fibrillation, atrial flutter or atrial tachycardias: a network meta-analysis.
Kukendrarajah K; Ahmad M; Carrington M; Ioannou A; Taylor J; Razvi Y; Papageorgiou N; Mead GE; Nevis IF; D'Ascenzo F; Wilton SB; Lambiase PD; Morillo CA; Kwong JS; Providencia R
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD013255. PubMed ID: 38828867
[TBL] [Abstract][Full Text] [Related]
5. WITHDRAWN: Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J; Mead GE
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD003713. PubMed ID: 29140557
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological cardioversion for atrial fibrillation and flutter.
Cordina J; Mead G
Cochrane Database Syst Rev; 2005 Apr; (2):CD003713. PubMed ID: 15846675
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of pad placement for electrical cardioversion of atrial fibrillation/flutter: a systematic review.
Kirkland S; Stiell I; AlShawabkeh T; Campbell S; Dickinson G; Rowe BH
Acad Emerg Med; 2014 Jul; 21(7):717-26. PubMed ID: 25117151
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Lafuente-Lafuente C; Valembois L; Bergmann JF; Belmin J
Cochrane Database Syst Rev; 2015 Mar; (3):CD005049. PubMed ID: 25820938
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Transoesophageal echocardiography-guided cardioversion of atrial fibrillation or flutter. Selection of a low-risk group for immediate cardioversion.
Roijer A; Eskilsson J; Olsson B
Eur Heart J; 2000 May; 21(10):837-47. PubMed ID: 10781356
[TBL] [Abstract][Full Text] [Related]
11. The RACE study in perspective of randomized studies on management of persistent atrial fibrillation.
Hagens VE; Van Gelder IC; Crijns HJ;
Card Electrophysiol Rev; 2003 Jun; 7(2):118-21. PubMed ID: 14618033
[TBL] [Abstract][Full Text] [Related]
12. Concomitant atrial fibrillation surgery for people undergoing cardiac surgery.
Huffman MD; Karmali KN; Berendsen MA; Andrei AC; Kruse J; McCarthy PM; Malaisrie SC
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011814. PubMed ID: 27551927
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation.
Valembois L; Audureau E; Takeda A; Jarzebowski W; Belmin J; Lafuente-Lafuente C
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD005049. PubMed ID: 31483500
[TBL] [Abstract][Full Text] [Related]
14. [Predictive factors of maintenance of sinus rhythm after direct current (DC) cardioversion of atrial fibrillation/atrial flutter].
Larsen MT; Lyngborg K; Pedersen F; Corell P
Ugeskr Laeger; 2005 Sep; 167(36):3408-12. PubMed ID: 16159494
[TBL] [Abstract][Full Text] [Related]
15. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
Boriani G; Diemberger I; Biffi M; Domenichini G; Martignani C; Valzania C; Branzi A
Int J Clin Pract; 2007 May; 61(5):748-56. PubMed ID: 17493088
[TBL] [Abstract][Full Text] [Related]
16. [Drug and electrical therapy of supraventricular tachyarrhythmias].
Heisel A; Jung J; Schieffer H
Z Kardiol; 2000; 89 Suppl 3():68-74. PubMed ID: 10810788
[TBL] [Abstract][Full Text] [Related]
17. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
18. Electrical versus pharmacological cardioversion for emergency department patients with acute atrial fibrillation (RAFF2): a partial factorial randomised trial.
Stiell IG; Sivilotti MLA; Taljaard M; Birnie D; Vadeboncoeur A; Hohl CM; McRae AD; Rowe BH; Brison RJ; Thiruganasambandamoorthy V; Macle L; Borgundvaag B; Morris J; Mercier E; Clement CM; Brinkhurst J; Sheehan C; Brown E; Nemnom MJ; Wells GA; Perry JJ
Lancet; 2020 Feb; 395(10221):339-349. PubMed ID: 32007169
[TBL] [Abstract][Full Text] [Related]
19. Thirty-day outcomes of emergency department patients undergoing electrical cardioversion for atrial fibrillation or flutter.
Xavier Scheuermeyer F; Grafstein E; Stenstrom R; Innes G; Poureslami I; Sighary M
Acad Emerg Med; 2010 Apr; 17(4):408-15. PubMed ID: 20370780
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of ablation for people with non-paroxysmal atrial fibrillation.
Nyong J; Amit G; Adler AJ; Owolabi OO; Perel P; Prieto-Merino D; Lambiase P; Casas JP; Morillo CA
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD012088. PubMed ID: 27871122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
